Can acalatinib/acalatinib tablets be taken for a long time?

Acalabrutinib/Acalabrutinib is a cancer drug used to treat adults with chronic lymphocytic leukemia (CLL), a type of blood cancer that affects B cells, a type of white blood cell. Acalabrutinib contains the active ingredient acalabrutinib and can be used alone (monotherapy) in patients with previously treated CLL. For patients who have not been previously treated for the disease, acotinib can be used alone or in combination with obinutuzumab, another cancer drug. At the same time, acotinib can also be used to treat mantle cell lymphoma and small lymphocytic lymphoma.

Several factors need to be considered as to whether acotinib can be taken long-term. The doctor will understand the individual's specific situation, including the type of disease, severity of the disease and other related health conditions, and the course and efficacy of acotinib will be determined based on the doctor's recommendations. Chronic lymphocytic leukemia is a chronic disease that requires ongoing treatment for most people. Usually doctors should give patients specific instructions. Acotinib is considered a consistently effective, long-term treatment, taken by mouth as one tablet twice daily, approximately 12 hours apart - at home or on the road. According to clinical guidelines for acotinib, patients should take the drug until disease progression or unacceptable toxicity occurs.

Therefore, drug treatment is a long-term process that may last for months or even years. The side effects and risks of acotinib also need to be considered. Some common side effects include headache, fatigue, nausea, etc. Serious side effects may include bleeding tendencies, infections, and heart problems. If you have any discomfort or questions, you should communicate with your doctor in time.